Coupa Software, Horizon Therapeutics And Some Other Big Stocks Moving Higher In Today's Pre-Market Session

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

• Coupa Software Incorporated COUP shares jumped 22.4% to $75.97 in pre-market trading. Private-equity firm Thoma Bravo is in advanced talks to buy Coupa Software and the transaction could be announced as early as this week, Bloomberg reported, citing people familiar with the matter. Coupa is also expected to release quarterly earnings after the closing bell today.
• Insmed Incorporated INSM climbed 15.1% to $21.24 in pre-market trading. Mizuho recently initiated coverage on Insmed with a Buy rating and announced a price target of $28.
• Horizon Therapeutics Public Limited Company HZNP surged 14.1% to $111.00 in pre-market trading. Bloomberg reported that Amgen is set to buy Horizon Therapeutics for about $116.50 per share.
• Turkcell Iletisim Hizmetleri A.S. TKC gained 8% to $4.59 in pre-market trading. Turkcell, last month, posted Q3 revenue of 14.20 billion Lira.
• AMC Entertainment Holdings, Inc. APE gained 6.6% to $0.82 in pre-market trading after declining around 7% on Friday.

Pre-IPO Offer: Get A Piece Of A Nearly $5T Global Opportunity By Joining BOXABL As An Early Shareholder At Just $0.80/Share

• Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
• Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
• Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.

Share Price: $0.80

Min. Investment: $1,000

Valuation: $3.5B

Click Here To Invest For Just $0.80/Share ($1000 Min)

Don’t forget to check out our premarket coverage here .

• Elanco Animal Health Incorporated ELAN gained 6.5% to $13.49 in pre-market trading. Elanco announced FDA approval of Bexacat, the first-of-its-kind oral feline diabetes treatment option.
• Frontline Ltd. FRO climbed 5.7% to $13.57 in pre-market trading. Frontline, last week, issued a Form424B3 filing highlighting a proposal to increase the company’s authorized share capital from $500 million to $600 million.
• The Gap, Inc. GPS gained 5% to $14.60 in pre-market trading after declining around 5% on Friday. Gap, last month, reported better-than-expected Q3 sales results.

Also check out this Oracle, Coupa Software And 3 Stocks To Watch Heading Into Monday.